Medifast (MED) news
Recent news
Banca Mediolanum: BofA global research raises price objective to EUR 25.5 from EUR 24.5
Bank of America’s global research team has raised its price objective for Banca Mediolanum (BMEDM) to EUR 25.5 from EUR 24.5, reflecting improved expectations for the Italian financial services group. The adjustment follows strong performance in 2025, during which Banca Mediolanum reported a record…
AInvest Wire · 8h agoMedifast - FY2026 revenue guidance $270-$300 mln; loss per share $0.25-$1.75
Medifast (NYSE: MED) reported its first-quarter 2026 financial results on May 4, 2026, revealing a revenue decline of 34.3% to $76.0 million compared to $115.7 million in the same period in 2025. The company attributed the drop to a 44.9% decrease in the number of active earning coaches, which fell…
AInvest Wire · Aug 3, 2026Medifast Inc: Backed by metabolic synchronization science & coach-led model, believe are on track to return to profitability in Q4
AInvest Wire · Aug 3, 2026Medifast to announce financial results for the second quarter ended June 30, 2026
Medifast (NYSE: MED) is scheduled to announce its financial results for the second quarter ended June 30, 2026, on Monday, August 3, 2026, after market close. The company will host a conference call to discuss the results, featuring key executives including Dan Chard, Chairman and Chief Executive…
AInvest Wire · Jul 20, 2026ImportantEgypt's oil minister: Egypt can help Saudi oil transit from Yanbu through SUMED to the Mediterranean
AInvest Wire · Mar 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.